Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-18
2011-01-18
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S360000
Reexamination Certificate
active
07871998
ABSTRACT:
Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
REFERENCES:
patent: 5306817 (1994-04-01), Thiruvengadam et al.
patent: 5631365 (1997-05-01), Rosenblum et al.
patent: 5633246 (1997-05-01), McKittrick et al.
patent: 5661145 (1997-08-01), Davis
patent: 5739321 (1998-04-01), Wu et al.
patent: 5744467 (1998-04-01), McKittrick et al.
patent: 5756470 (1998-05-01), Yumibe et al.
patent: 5767115 (1998-06-01), Rosenblum et al.
patent: 5846966 (1998-12-01), Rosenblum et al.
patent: 5886171 (1999-03-01), Wu et al.
patent: 5919672 (1999-07-01), Homann et al.
patent: RE37721 (2002-05-01), Rosenblum et al.
patent: 7235543 (2007-06-01), Burnett et al.
patent: 7368562 (2008-05-01), Burnett et al.
patent: 7470678 (2008-12-01), Starke et al.
patent: 2002/0137690 (2002-09-01), Ghosai et al.
patent: 2003/0119428 (2003-06-01), Davis et al.
patent: 2003/0119757 (2003-06-01), Davis
patent: 2004/0018060 (2004-01-01), Knezek et al.
patent: 2004/0018061 (2004-01-01), Jansson
patent: 2004/0254369 (2004-12-01), Framroze
patent: 2005/0096307 (2005-05-01), Graziano
patent: 2005/0267049 (2005-12-01), Goulet et al.
patent: 2006/0046996 (2006-03-01), Aoki et al.
patent: 2006/0069080 (2006-03-01), Veltri
patent: 2007/0049748 (2007-03-01), Uppala et al.
patent: 2007/0078098 (2007-04-01), DeVita et al.
patent: 2007/0129540 (2007-06-01), Framroze
patent: 2007/0142304 (2007-06-01), Alenfalk et al.
patent: 2007/0155674 (2007-07-01), Burnett et al.
patent: 2007/0155675 (2007-07-01), Burnett et al.
patent: 2008/0064676 (2008-03-01), Alenfalk et al.
patent: 2008/0070890 (2008-03-01), Burnett et al.
patent: 2009/0069285 (2009-03-01), Lemurell et al.
patent: 2010/0048529 (2010-02-01), Dahlstrom et al.
patent: 2010/0048530 (2010-02-01), Dahlstrom et al.
patent: 2010/0125059 (2010-05-01), Nakano et al.
patent: 524595 (1993-01-01), None
patent: 1413331 (2001-09-01), None
patent: 0792264 (2002-02-01), None
patent: 1362855 (2003-11-01), None
patent: 9302048 (1993-02-01), None
patent: 9414433 (1994-07-01), None
patent: 9417038 (1994-08-01), None
patent: 9501961 (1995-01-01), None
patent: 9508532 (1995-03-01), None
patent: 9526334 (1995-10-01), None
patent: 9535277 (1995-12-01), None
patent: 9609827 (1996-04-01), None
patent: 9616037 (1996-05-01), None
patent: 9619450 (1996-06-01), None
patent: 9716424 (1997-05-01), None
patent: 9716455 (1997-05-01), None
patent: 9745406 (1997-12-01), None
patent: 0020623 (2000-04-01), None
patent: 0034240 (2000-06-01), None
patent: 0038725 (2000-07-01), None
patent: 0060107 (2000-10-01), None
patent: 0063703 (2000-10-01), None
patent: 0250027 (2002-06-01), None
patent: 0250060 (2002-06-01), None
patent: 0250068 (2002-06-01), None
patent: 0250090 (2002-06-01), None
patent: 02018432 (2002-07-01), None
patent: 02058685 (2002-08-01), None
patent: 02058696 (2002-08-01), None
patent: 02058731 (2002-08-01), None
patent: 02058732 (2002-08-01), None
patent: 02058733 (2002-08-01), None
patent: 02058734 (2002-08-01), None
patent: 02066464 (2002-08-01), None
patent: 02072104 (2002-09-01), None
patent: 02079174 (2002-10-01), None
patent: 02096415 (2002-12-01), None
patent: 03026643 (2003-04-01), None
patent: 03026644 (2003-04-01), None
patent: 03088962 (2003-10-01), None
patent: 2004000803 (2003-12-01), None
patent: 2004000804 (2003-12-01), None
patent: 2004000805 (2003-12-01), None
patent: 2004005247 (2004-01-01), None
patent: 2004010948 (2004-02-01), None
patent: 2004010993 (2004-02-01), None
patent: 2004014947 (2004-02-01), None
patent: 2004043456 (2004-05-01), None
patent: 2004043457 (2004-05-01), None
patent: 2004081002 (2004-09-01), None
patent: 2004099132 (2004-11-01), None
patent: 2004107958 (2004-12-01), None
patent: 2005000353 (2005-01-01), None
patent: 2005021495 (2005-03-01), None
patent: 2005042692 (2005-05-01), None
patent: 2005044256 (2005-05-01), None
patent: 2005047248 (2005-05-01), None
patent: 2005049592 (2005-06-01), None
patent: 2005058316 (2005-06-01), None
patent: 2005033100 (2005-07-01), None
patent: 2005061451 (2005-07-01), None
patent: 2005061452 (2005-07-01), None
patent: 2005062824 (2005-07-01), None
patent: 2005062897 (2005-07-01), None
patent: 2005066120 (2005-07-01), None
patent: 2005067903 (2005-07-01), None
patent: 2005069900 (2005-08-01), None
patent: 2005113495 (2005-12-01), None
patent: 2005113496 (2005-12-01), None
patent: 2006017257 (2006-02-01), None
patent: 2006060808 (2006-06-01), None
patent: 2006068990 (2006-06-01), None
patent: 2006072957 (2006-07-01), None
patent: 2006086562 (2006-08-01), None
patent: 2006102674 (2006-09-01), None
patent: 2006107936 (2006-10-01), None
patent: 2006116499 (2006-11-01), None
patent: 2006121861 (2006-11-01), None
patent: 2006122186 (2006-11-01), None
patent: 2006122216 (2006-11-01), None
patent: 2006124713 (2006-11-01), None
patent: 2006127893 (2006-11-01), None
patent: 2006134604 (2006-12-01), None
patent: 2006137080 (2006-12-01), None
patent: 2006137782 (2006-12-01), None
patent: 2006137792 (2006-12-01), None
patent: 2006137793 (2006-12-01), None
patent: 2006137794 (2006-12-01), None
patent: 2006137795 (2006-12-01), None
patent: 2006137796 (2006-12-01), None
patent: 2006137797 (2006-12-01), None
patent: 2006138163 (2006-12-01), None
patent: 2007003365 (2007-01-01), None
patent: 2007008529 (2007-01-01), None
patent: 2007008541 (2007-01-01), None
patent: 2007015161 (2007-02-01), None
patent: 2007016643 (2007-02-01), None
patent: 2007017705 (2007-02-01), None
patent: 2007030721 (2007-03-01), None
patent: 2007058335 (2007-05-01), None
patent: 2007059871 (2007-05-01), None
patent: 2007072088 (2007-06-01), None
patent: 2007075702 (2007-07-01), None
patent: 2004005247 (2007-11-01), None
McKittrick et al., “Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity,” (1998) 41(5):752-759.
Notice of allowance dated Jul. 31, 2008 for U.S. Appl. No. 10/519,897.
Office Action dated Feb. 28, 2008 for U.S. Appl. No. 10/519,897.
Notice of allowance dated Aug. 28, 2007 for U.S. Appl. No. 10/519,897.
Office Action dated May 1, 2007 for U.S. Appl. No. 10/519,897.
Vaccaro et al., “Carboxy-substituted 2-azetidinones as cholesterol absorption inhibitors,” Bioorganic & Medicinal Chemistry Letters (1998) 8:319-322.
Clader et al., “2-Azetidinone Cholesterol Absorption Inhibitors: Structure-Activity Relationships on the HeterocyclicNucleus,” J. Med Chem (1996) 39:3684-3693.
McKittrick et al., Stereoselective synthesis and biological activity of cis azetidinones as cholesterol absorptioninhibitors, Bioorganic & Medicinal Chemistry Letters (1996) 6(16):1947-1950.
Burnett et al., “2-Azetidinones as Inhibitors of Cholesterol Absorption,” J. Med Chem (1994) 12:1733-1736.
Castaner et al., “Ezetimibe Hypolipidemic, Cholesterol absorption inhibitor,” Drugs of the Future (2000) 25(7):679-685.
Vaccaro et al., “Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: Enhanced potency by modification ofthe sugar,” Bioorganic & Medicinal Chemistry Letters (1998) 8:313-318.
Fu et al., “Process for preparing Ezetimibe intermediate by an acid enhanced chemo- and enantioselective CBScatalyzed ketone reduction,” Tetrahedron Letters (2003) 44:801-804.
Kirkup et al., “(i)-SCH 57939: synthesis and pharmacological properties of a potent, metabolically stable cholesterolabsorption inhibitor,” Bioorganic & Medicinal Chemistry Letters (1996) 6(17):2069-2072.
Rosenblum et al., “Discovery of 1-(4-fluorophenyl)-(3R)[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption.,” J. Med Chem (1998) 41:973-980.
Wu et al., “A Novel One-Step Diastereo- and Enanti
Alenfalk Susanne
Dahlström Mikael
Hunegnaw Fana
Karlsson Staffan
Lemurell Malin
Astrazeneca AB
Berch Mark L
Pepper Hamilton LLP
LandOfFree
Diphenylazetidinone derivatives possessing cholesterol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diphenylazetidinone derivatives possessing cholesterol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphenylazetidinone derivatives possessing cholesterol... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2734674